Role of Litigation in Defining Drug Risks_JAMA / BMJ
Documents uncovered during the course of litigation shed light on real risks of drug-induced harm that would not otherwise be known.
-
-
Are Lipid lowering (Statins) Guidelines Evidence-Based? Lancet
The authors argue that recommendations for the expanded use of statins to stave off cardiovascular disease are NOT supported by the evidence.
-
Eli Lilly Lies About Zyprexa_NYT Editorial Calls for CongressionalHearings
The question is: will Eli Lilly succeed, once again, to divert public attention from the revelations contained in its internal documents about the company's illegal marketing practices and its failure to warn about lethal risks posed by its product?
-
Eli Lilly Documents Show Risks of Zyprexa were deliberately played down_NYT
NY Times reports: In March 2002, Lilly rejected plans to give psychiatrists guidance about how
to treat diabetes, "worrying that doing so would tarnish Zyprexa's reputation." -
Flu Vaccine–where is the evidence?
This is an addendum to yesterday's Infomail in which we disseminated disinformation issued by the U.S. Center for Disease Control (CDC). www.ahrp.org/cms/content/view/396/80
-
Risks: Drugs / Vaccines / Trials / Treatments
Risks: Drugs / Vaccines / Trials / Treatment Evidence of antidepressant harm Oct 14, 2005: Andrew Finkelstein Letter to Dr. Russell Katz, Director, Neuropharmacological Drug Products, FDA about FDA’s Failure to Warn about Neurontin-Suicides Aug 29: FDA Response to Utah Court Must Be Truthful Re: Zoloft / SSRI Suicidal Risks…
-
Published Clinical Trials Contradict Claimed Benefits – Front Page Pill Pushers
Published Clinical Trials Contradict Claimed Benefits – Front Page Pill Pushers Tue Aug 16, 2005 Two items from the BMJ A systemic review of 22 randomized clinical trials of Alzheimer’s disease treatments in the BMJ found the studies to have suffered from flawed methodology and to have revealed that commonly…
-
Efforts to Expand Emergency Exception from Informed Consent
Efforts to Expand Emergency Exception from Informed Consent Thu, 6 Oct 2005 The following announcement posted to the IRB Forum by Dr. Robert Nelson, a KOL (key opinion leader) within the close-knit IRB community– who serve as gatekeepers of human research –demosntrates that the culture of secrecy is entrenched in…
-
Two-thirds foster care children in Mass on psych drugs_Globe /Psychiatry: Soviet Experience–American Fallacy
Two-thirds foster care children in Mass on psych drugs_Globe Psychiatry: Soviet Experience–American Fallacy Wed, 11 Aug 2004 The Boston Globe reports that 2/3 of children in state care in Massachusetts are being “treated” for mental illness with psychotropic drugs. Marie Parente, a legislator, and parents call for disclosure of “how…
-
Just How Effective are Medical Screening Tests?
Just How Effective are Medical Screening Tests? Mon, 17 Nov 2003 A investigative report in the Guardian (UK) takes a critical view of medical screening for early detection of latent diseases. Contrary to the promoters of medical screening tests, there is scant evidence that early detection actually saves lives. The…
-
Protecting People w Mental Disabilities & Impairments against Biomedical Research Abuse
Protecting People with Mental Disabilities and Impairments against Biomedical Research Abuse[*] By John H. Noble, Jr., Ph.D, The Catholic University of America, Washington, DC, USA Vera Hassner Sharav, MLS, Alliance for Human Research Protection, New York, USA People with mental disabilities and impairments historically have been targeted by biomedical researchers…
-
AHRP Position Statement on Mental Health Screening – FDA Hearing Re: Drug Advertising
AHRP Position Statement on Mental Health Screening – FDA Hearing Re: Drug Advertising Wed, 02 Nov 2005 FDA is holding public hearings (Nov 1, 2) Re:Â Direct-to-Consumer Promotion of Medical Products at: National Transportation Safety Board Boardroom and Conference Center 429 L’Enfant Plaza, SW., Washington, DC 2 Time: 9:00 –5:00….